NCT00353301
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,811 public trials
2,094 recruiting studies
Carcinoma trial results
NCT01439724
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +11 more
- Locations
-
- Instituto Nacional de Cancer Rio de Janeiro, Brazil
NCT01358097
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +15 more
- Locations
-
- Icahn School of Medicine at Mount Sinai, Otolaryngology - Head and Neck Surgery New York, United States
NCT00971932
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Research Site Aichi, Japan
- National Cancer Center East Hospital Chiba, Japan
- Research Site Ehime, Japan
- Research Site Hokkaido, Japan
NCT01243359
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT00815087
- Conditions
- Carcinoma, Deglutition Disorders, Digestive System Diseases, +16 more
- Locations
-
Not specified
Completed
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
NCT01712919
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Jiangsu Cancer Hospital Nanjing, Jiangsu, China
NCT02094105
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Cancer Institute/Hospital of Ci County Handan, Hebei, China
NCT00356460
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
- Dana Farber/Harvard Cancer Center, Dana Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital Cambridge, Massachusetts, United States
Completed
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
NCT00142467
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States